0 NASDAQ Companies - July 29, 2019Akcea Therapeutics to Hold Second Quarter 2019 Financial Results WebcastRead More
0 NASDAQ Companies - July 29, 2019Amicus Therapeutics to Announce Second Quarter 2019 Financial Results on August 8, 2019Read More
0 NASDAQ Companies - July 29, 2019European Medicines Agency Grants PRIME Access to ProQR’s Sepofarsen for Leber’s Congenital Amaurosis 10Read More
0 NASDAQ Companies - July 29, 2019Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal RezafunginRead More
0 NASDAQ Companies - July 29, 2019Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich SyndromeRead More
0 NASDAQ Companies - July 29, 2019Axogen, Inc. to Participate at Canaccord Genuity 39th Annual Growth ConferenceRead More
0 NASDAQ Companies - July 29, 2019Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for the Treatment of Rett SyndromeRead More
0 NASDAQ Companies - July 29, 2019American Electric Technologies Completes Share Exchange with Stabilis EnergyRead More
0 NASDAQ Companies - July 29, 2019Stemline Therapeutics to Host Conference Call on Second Quarter 2019 Financial Results on August 2, 2019Read More
0 TSX News - July 29, 2019Silver Bull Makes New Discovery and Intercepts 13.25 Meters of Massive Sulphide Grading 9.05% Zinc, 2.12% Lead and 16g/t Silver, Including 5.85 Meters Grading 11.93% Zinc, 2.83% Lead and 24g/t Silver in Coahuila, MexicoRead More
